Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Tate

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Anticancer Research|July 5, 2022
Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Gynecologic Oncology|August 13, 2017
Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation studyShinichi Tate, Kazuyoshi Kato, Kyoko Nishikimi, et al.
Anticancer Research|April 30, 2022
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Acta Cytologica|May 22, 2022
Influence of Estradiol-Producing Ovarian Tumors on the Maturation Index of Cervical Cytology in Postmenopausal WomenAyumu Matsuoka, Shinichi Tate, Satoyo Otsuka, et al.
Cancers|August 27, 2021
Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian CancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
The Journal of Obstetrics and Gynaecology Research|February 15, 2023
Delayed postrenal failure due to progression of asymptomatic hydronephrosis following hysterectomyMana Haruishi, Ayumu Matsuoka, Shinichi Tate, et al.
Nutrients|December 11, 2022
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal CancerNaoko Nomoto, Shinichi Tate, Makoto Arai, et al.
The Journal of Reproductive Medicine|August 4, 2010
Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasiaHideo Matsui, Maki Kihara, Hirokazu Usui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2004
[Neurotoxicity of weekly TP (weekly paclitaxel + consecutive low-dose CDDP) therapy]Shinichi Tate, Yasuo Hirai, Hideaki Iwasaki, et al.
In Vivo (Athens, Greece)|September 13, 2022
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal CancersAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Anticancer Research|July 5, 2022
Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Gynecologic Oncology|August 13, 2017
Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation studyShinichi Tate, Kazuyoshi Kato, Kyoko Nishikimi, et al.
Anticancer Research|April 30, 2022
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian CancerShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Acta Cytologica|May 22, 2022
Influence of Estradiol-Producing Ovarian Tumors on the Maturation Index of Cervical Cytology in Postmenopausal WomenAyumu Matsuoka, Shinichi Tate, Satoyo Otsuka, et al.
Cancers|August 27, 2021
Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian CancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
The Journal of Obstetrics and Gynaecology Research|February 15, 2023
Delayed postrenal failure due to progression of asymptomatic hydronephrosis following hysterectomyMana Haruishi, Ayumu Matsuoka, Shinichi Tate, et al.
Nutrients|December 11, 2022
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal CancerNaoko Nomoto, Shinichi Tate, Makoto Arai, et al.
The Journal of Reproductive Medicine|August 4, 2010
Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasiaHideo Matsui, Maki Kihara, Hirokazu Usui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2004
[Neurotoxicity of weekly TP (weekly paclitaxel + consecutive low-dose CDDP) therapy]Shinichi Tate, Yasuo Hirai, Hideaki Iwasaki, et al.
In Vivo (Athens, Greece)|September 13, 2022
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal CancersAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Pageof 6